Accelerate Cures/Treatments for All Dementias (ACT-AD), www.act-ad.org, is a coalition of more than 50 national non-profit health professional, patient, business, health provider and consumer organizations seeking to accelerate development of potential cures and treatments for Alzheimer’s disease (AD) and all dementias.

About ACT-AD Advisory Board Coalition Members Membership Information

  Recent News & Updates
All Updates All Resources Press Room

Sponsor Spotlight: Avanir’s Sanjay Dubé, M.D.
Update
13th Annual FDA/ACT-AD Allies Meeting Recap
Update
Webinar: Research and Clinical Development in Lewy Body Dementia
Resource
ACT-AD Member Spotlight: BrightFocus Foundation
Update
Webinar: The Emerging Antimicrobial Protection Hypothesis of Alzheimer’s Disease
Resource
Webinar: If You Build It, Will They Come? Strategies for Alzheimer’s Disease Clinical Trial Recruitment
Resource
ACT-AD at the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Update
ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance
Update